Literature DB >> 12533051

Disseminated granulocytic sarcoma treated with allogeneic peripheral blood stem-cell transplantation.

W S Stevenson1, P C Vincent, H J Iland.   

Abstract

Primary granulocytic sarcoma is a rare disorder that presents as an extramedullary myeloid cell tumour. In this case, we describe a 35-year-old woman who developed widely disseminated granulocytic sarcomas three months after she received local radiotherapy to a primary granulocytic sarcoma of the cervical spine. These disseminated sarcomas initially responded to combination chemotherapy but this approach was only partly successful as the woman was left with increasing residual disease in the mediastinum. She was then treated with an allogeneic peripheral blood stem-cell transplant that led to complete resolution of her disease. This case demonstrates the effectiveness of allogeneic stem-cell transplantation in the treatment of progressive granulocytic sarcoma present after high-dose chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12533051     DOI: 10.1080/1042819021000016104

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  2 in total

1.  Refractory de novo myeloid sarcoma: a case report and therapeutic strategy based on bone marrow minimal residual disease.

Authors:  Daichi Inoue; Yuya Nagai; Takaharu Kimura; Sonoko Shimoji; Minako Mori; Katsuhiro Togami; Sumie Tabata; Masayuki Kurata; Akiko Matsushita; Kiminari Ito; Hisako Hashimoto; Hayato Maruoka; Eiko Yamashita; Kenichi Nagai; Yukihiro Imai; Hirohumi Shirane; Takayuki Takahashi
Journal:  Int J Hematol       Date:  2009-06-10       Impact factor: 2.490

2.  Isolated granulocytic sarcoma of the small intestine successfully treated with chemotherapy and bone marrow transplantation.

Authors:  Yukiko Kitagawa; Yuichi Sameshima; Hiroko Shiozaki; Shinpei Ogawa; Akihiro Masuda; Shin-Ichiro Mori; Masanao Teramura; Michihiko Masuda; Shingo Kameoka; Toshiko Motoji
Journal:  Int J Hematol       Date:  2008-05       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.